Table 6.

Multivariable model between OSA and risk of incident metabolic, pulmonary, and neurocognitive sequelae 1 year after COVID-19.

Variables	Model 1 (OR, 95%-CI)	p-value	Model 2 (OR, 95%-CI)	p-value
DLCO	9.3 (1.5–181)	*0.04	13.4 (0.6–182)	0.16
Insulin resistance	4.4 (1.2–18.2)	*0.02	2.5 (0.3–18.1)	0.33
Diabetes Mellitus	3.6 (0.93–18.1)	0.07	1.5 (0.2–10.5)	0.62
Uncontrolled HTA	2.6 (0.89–8.1)	0.08	1.8 (0.3–8.7)	0.45
MOCA	2.9 (1.85–11.3)	*0.04	4.2 (0.7–26)	0.10

DLCO, Diffusing Capacity of The Lungs for Carbon Monoxide; MOCA, Montreal cognitive assessment. Additionally we performed a logistic regression analysis, as confounder analysis, we conducted an unadjusted an adjusted model by age, gender, BMI, development of ARDS during the acute infection. The values were reported as Odds ratios (OR) with a 95% confidence interval (95%-CI).

*Statistically significant with p <0.05. and highlighted in bold.